comprehensive -WSS

comprehensive

author：hotspot 2025-09-27 09:38:01 - browse：22548

Coronary medical stent -- health business coverage from STAT — Adobe

Coronary stenting is, by some measures, the most overused procedure in hospitals. The problem costs the health system millions and unnecessarily exposes patients to risks of blood clots, torn arteries, infections, and other life-threatening injuries.

In 2020, Medicare started paying physicians to place stents, balloons, and perform other procedures designed to open clogged coronary arteries outside of hospitals, in less expensive outpatient settings. It didn’t take long for private equity firms to catch on. They’ve been racing to buy up cardiology practices ever since, rolling them into bigger and bigger chains with an eye toward reselling them at a profit.

It’s similar to what happened with orthopedics and gastroenterology, two specialties that have become saturated with private equity money since more procedures went outpatient. Research in other specialties has shown that these financial investors tend to usher in more patients, ramp up surgeries, and jack up prices, effectively increasing spending even as government policies try to lower it. Now, experts say they fear the same thing could happen in cardiology, a field with a long track record of overuse.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： CRISPR gene editing developments we’re watching in 2024

Wikipedia

hotspot

WSS

The biotech scorecard for Q4: 16 stock

Study points to new risk in gene therapy death of Terry Horgan

What we owe ALS patients — and why one company fell short

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Medicare Advantage beneficiaries sue Humana over algorithm use

Editas, Vertex strike deal on CRISPR

hotspot

comprehensive

explore

Supreme Court strikes down use of affirmative action

CDC picks Alphabet's Verily for wasterwater surveillance contract

DIEP, the 'gold standard' of breast reconstruction, is under threat

Lawsuit highlights wrinkle for disputes over surprise medical bills

Bright Health sells Medicare Advantage business to Molina

6 solutions to address cancer drug shortages and others

Heart attack and stroke risk calculators need revising

Nobel honors Karikó and Weissman's enduring partnership

BioMarin wins approval for gene therapy to treat hemophilia A

Three trends to watch in biotech in 2024

focus

Stop Congress from blocking public access to science

Nobel honors Karikó and Weissman's enduring partnership

Stop Congress from blocking public access to science

The Karikó problem: Lessons for funding basic research

Why health records don't always know when patients are dead

CRISPR base editing slashes cholesterol levels in monkeys

focus

Wikipedia

hotspot

hotspot